RIVERSIDE, Calif. - A California federal judge on April 19 ruled that a generic drug manufacturer adequately pleaded its False Claims Act allegations that Sanofi-Aventis S.A. overcharged federal health care programs for the anti-coagulant drug Lovenox (Amphastar Pharmaceuticals Inc. v. Aventis Pharma SA, et al., No. EDCV-09-0023 MJG, C.D. Calif., E. Div.)....(read more)Image may be NSFW.
Clik here to view.
Clik here to view.
